CD274 and neoplasm: Taken together, our study indicates that restricting cystine availability or inhibiting cystine transport reprogrammes macrophages into the anti‐tumor M1‐like phenotype, this effect is further potentiated when combined with PD‐L1/PD‐1 immunotherapy (Figure 8B).